In a recent study, CD8+ T cells from long-term antiviral-treated chronic hepatitis B (CHB) patients demonstrated higher KLRG1 expression than CD8+ T cells from healthy controls (HCs) [24]. This evidence concerns the gene CD8A and chronic hepatitis B virus infection.